Abstract
Over the past decade, a number of ribosomal proteins (RPs) have been found to have a role in activating the tumor suppressor p53 by directly binding to MDM2 and impeding its activity toward p53. Herein, we report that RPL5 and RPL11 can also enhance the transcriptional activity of a p53 homolog TAp73, but through a distinct mechanism. Interestingly, even though RPL5 and RPL11 were not shown to bind to p53, they were able to directly associate with the transactivation domain of TAp73 independently of MDM2 in response to RS. This association led to perturbation of the MDM2-TAp73 interaction, consequently preventing MDM2 from its association with TAp73 target gene promoters. Furthermore, ectopic expression of RPL5 or RPL11 markedly induced TAp73 transcriptional activity by antagonizing MDM2 suppression. Conversely, ablation of either of the RPs compromised TAp73 transcriptional activity, as evident by the reduction of p21 and Puma expression, in response to 5-fluorouracil (5-FU). Consistently, overexpression of RPL5 or RPL11 enhanced, but knockdown of either of them hampered, TAp73-mediated apoptosis. Intriguingly, simultaneous knockdown of TAp73 and either of the RPs was required for rescuing the 5-FU-triggered S-phase arrest of p53-null tumor cells. These results demonstrate a novel mechanism underlying the inhibition of tumor cell proliferation and growth by these two RPs via TAp73 activation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- RP:
-
ribosomal protein
- RS:
-
ribosomal stress
- TA domain:
-
transactivation domain
- ΔN:
-
deleted N-terminal
- 5-FU:
-
5-fluorouracil
- Doxy:
-
doxycycline
- IP:
-
immunoprecipitation
- IB:
-
immunoblot
- ChIP:
-
chromatin immunoprecipitation
- LC:
-
light chain
- FACS:
-
fluorescence activated cell sorting
- RT:
-
Reverse transcription
- qPCR:
-
quantitative PCR
References
Levine AJ, Oren M . The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9: 749–758.
Stiewe T . The p53 family in differentiation and tumorigenesis. Nat Rev Cancer 2007; 7: 165–168.
Oswald C, Stiewe T . In good times and bad: p73 in cancer. Cell Cycle 2008; 7: 1726–1731.
Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22: 2677–2691.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809–819.
Melino G, De Laurenzi V, Vousden KH . p73: friend or foe in tumorigenesis. Nat Rev Cancer 2002; 2: 605–615.
Jost CA, Marin MC, Kaelin WG Jr . p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997; 389: 191–194.
Wu X, Bayle JH, Olson D, Levine AJ . The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993; 7: 1126–1132.
Barak Y, Juven T, Haffner R, Oren M . mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12: 461–468.
Fuchs SY, Adler V, Buschmann T, Wu X, Ronai Z . Mdm2 association with p53 targets its ubiquitination. Oncogene 1998; 17: 2543–2547.
Kubbutat MH, Jones SN, Vousden KH . Regulation of p53 stability by Mdm2. Nature 1997; 387: 299–303.
Haupt Y, Maya R, Kazaz A, Oren M . Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296–299.
Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J et al. The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol 2010; 17: 982–989.
Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 1993; 362: 857–860.
Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X et al. MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol 1999; 19: 3257–3266.
Dobbelstein M, Wienzek S, Konig C, Roth J . Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene 1999; 18: 2101–2106.
Balint E, Bates S, Vousden KH . Mdm2 binds p73 alpha without targeting degradation. Oncogene 1999; 18: 3923–3929.
Dai MS, Lu H . Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004; 279: 44475–44482.
Bai D, Zhang J, Xiao W, Zheng X . Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress. Nucleic Acids Res 2014; 42: 1799–1811.
Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003; 23: 8902–8912.
Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH . Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003; 3: 577–587.
Jin A, Itahana K, O'Keefe K, Zhang Y . Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004; 24: 7669–7680.
Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H et al. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004; 24: 7654–7668.
Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007; 26: 5029–5037.
Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 2009; 35: 316–326.
Zhou X, Hao Q, Liao J, Zhang Q, Lu H . Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 2013; 32: 388–396.
Sun XX, DeVine T, Challagundla KB, Dai MS . Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. J Biol Chem 2011; 286: 22730–22741.
Zhang Y, Lu H . Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16: 369–377.
Zhou X, Liao JM, Liao WJ, Lu H . Scission of the p53-MDM2 loop by ribosomal proteins. Genes Cancer 2012; 3: 298–310.
Sun XX, Dai MS, Lu H . Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J Biol Chem 2008; 283: 12387–12392.
Sun XX, Dai MS, Lu H . 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem 2007; 282: 8052–8059.
Dai MS, Sun XX, Lu H . Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 2008; 28: 4365–4376.
Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstrom MS et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010; 18: 231–243.
Nakano K, Balint E, Ashcroft M, Vousden KH . A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 2000; 19: 4283–4289.
Zhang Q, Xiao H, Chai SC, Hoang QQ, Lu H . Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation. J Biol Chem 2011; 286: 38264–38274.
Mahata B, Sundqvist A, Xirodimas DP . Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Oncogene 2012; 31: 3060–3071.
Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A et al. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 2008; 22: 2496–2506.
Bendjennat M, Boulaire J, Jascur T, Brickner H, Barbier V, Sarasin A et al. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003; 114: 599–610.
Jin Y, Lee H, Zeng SX, Dai MS, Lu H . MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J 2003; 22: 6365–6377.
Jin Y, Zeng SX, Sun XX, Lee H, Blattner C, Xiao Z et al. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol 2008; 28: 1218–1229.
Li X, Amazit L, Long W, Lonard DM, Monaco JJ, O'Malley BW et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007; 26: 831–842.
Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM . Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007; 26: 843–852.
Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE et al. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000; 5: 403–410.
Chen X, Chi Y, Bloecher A, Aebersold R, Clurman BE, Roberts JM et al. N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol Cell 2004; 16: 839–847.
Lee H, Zeng SX, Lu H . UV Induces p21 rapid turnover independently of ubiquitin and Skp2. J Biol Chem 2006; 281: 26876–26883.
Liao JM, Zhou X, Gatignol A, Lu H . Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex. Oncogene 2013; e-pub ahead of print 21 October 2013; doi:doi:10.1038/onc.2013.430.
Ongkeko WM, Wang XQ, Siu WY, Lau AW, Yamashita K, Harris AL et al. MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr Biol 1999; 9: 829–832.
Zdzalik M, Pustelny K, Kedracka-Krok S, Huben K, Pecak A, Wladyka B et al. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Cell Cycle 2010; 9: 4584–4591.
Zeng X, Li X, Miller A, Yuan Z, Yuan W, Kwok RP et al. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol Cell Biol 2000; 20: 1299–1310.
Gonzalez S, Prives C, Cordon-Cardo C . p73alpha regulation by Chk1 in response to DNA damage. Mol Cell Biol 2003; 23: 8161–8171.
Horn HF, Vousden KH . Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 2008; 27: 5774–5784.
Dai MS, Arnold H, Sun XX, Sears R, Lu H . Inhibition of c-Myc activity by ribosomal protein L11. EMBO J 2007; 26: 3332–3345.
Challagundla KB, Sun XX, Zhang X, DeVine T, Zhang Q, Sears RC et al. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol Cell Biol 2011; 31: 4007–4021.
Chen MQ, Zhang AH, Zhang Q, Zhang BC, Nan J, Li X et al. Arabidopsis NMD3 is required for nuclear export of 60S ribosomal subunits and affects secondary cell wall thickening. PLoS One 2012; 7: e35904.
Liao JM, Lu H . ChIP for identification of p53 responsive DNA promoters. Methods Mol Biol 2013; 962: 201–210.
Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H . MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem 2002; 277: 30838–30843.
Jin Y, Dai MS, Lu SZ, Xu Y, Luo Z, Zhao Y et al. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 2006; 25: 1207–1218.
Acknowledgements
We thank Dr. Karen H Vousden for the TAp73-inducible cell line, Dr. Yi Sun for the RPS27a construct, and Mary Price for FACS analyses. HL was supported by NIH-NCI grants CA095441, CA 079721, CA129828 and CA 172468.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by KH Vousden
Rights and permissions
About this article
Cite this article
Zhou, X., Hao, Q., Zhang, Q. et al. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition. Cell Death Differ 22, 755–766 (2015). https://doi.org/10.1038/cdd.2014.167
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2014.167
This article is cited by
-
Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways
Biomarker Research (2024)
-
RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression
Cell Death & Disease (2023)
-
p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
Cell Death & Differentiation (2022)
-
PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53
Cell Death & Disease (2021)
-
p53 induces ARTS to promote mitochondrial apoptosis
Cell Death & Disease (2021)
